Intellectual Property Litigation - - BioPharm International

ADVERTISEMENT

Intellectual Property Litigation


BioPharm International
Volume 1, Issue 8

13. Bibby K, Davis J, Jones, J. Biopharmaceuticals—moving to centre stage. BioPeople. 2003:10 (available at http:// http://www.imshealth.com/vgn/images/portal/cit_40000873/43028586Bio_Moving_to_Centre_Stage.pdf ).

14. Benassi J, Wolff J. The rise of generic and "branded generics" cause dramatic increase in pharmaceutical patent litigation. IP Today. January 2004:8.

15. American Intellectual Property Law Association (AIPLA). Report of the Economic Survey. Arlington, Va: AIPLA; 2003:Table 22.

Gary N. Frischling, J.D., is a partner at Irell & Manella LLP, 1800 Avenue of the Stars, Suite 900, Los Angeles, CA 90067, 310.277.1010, fax 310.203.7199,

Keith A. Orso, J.D., is an associate at Irell & Manella LLP, 1800 Avenue of the Stars, Suite 900, Los Angeles, CA 90067, 310.277.1010, fax 310.203.7199,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis and GSK Trade Assets
April 22, 2014
Lilly to Acquire Novartis Animal Health
April 22, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here